La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed.

Slides:



Advertisements
Similar presentations
From: Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis Ann Intern Med. 1995;122(4): doi: /
Advertisements

Volume 3, Issue 4, Pages (April 2013)
Volume 118, Issue 1, Pages (January 2000)
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Volume 15, Issue 6, Pages (June 2007)
Volume 16, Issue 3, Pages (March 2008)
Volume 131, Issue 4, Pages (October 2006)
Novel Cis Element for Tissue-Specific Transcription of Rat Platelet-Derived Growth Factor β-Receptor Gene by Yasunori Takata, Yutaka Kitami, Tomikazu Fukuoka,
Volume 22, Issue 7, Pages (July 2015)
Volume 130, Issue 3, Pages (March 2006)
Volume 127, Issue 4, Pages (October 2004)
Volume 141, Issue 1, Pages e2 (July 2011)
WT1 Promotes Invasion of NSCLC via Suppression of CDH1
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 2, Pages (August 2007)
Volume 64, Issue 6, Pages (June 2016)
SDHB deficiency promotes TGFβ-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3/4  Haiyu Wang,
Volume 145, Issue 6, Pages e1 (December 2013)
Volume 128, Issue 1, Pages (January 2005)
Volume 127, Issue 4, Pages (October 2004)
Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes  Ying Shan, Jianyu Zheng, Richard.
Volume 3, Issue 4, Pages (April 2013)
Volume 141, Issue 3, Pages (September 2011)
Volume 137, Issue 2, Pages (August 2009)
Volume 128, Issue 3, Pages (March 2005)
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
PTF1α/p48 and cell proliferation
Volume 120, Issue 4, Pages (March 2001)
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Volume 135, Issue 5, Pages e3 (November 2008)
Volume 131, Issue 4, Pages (October 2006)
Volume 118, Issue 1, Pages (January 2000)
Translational Regulatory Mechanisms Generate N-Terminal Glucocorticoid Receptor Isoforms with Unique Transcriptional Target Genes  Nick Z. Lu, John A.
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 62, Issue 4, Pages (October 2002)
Volume 137, Issue 5, Pages (November 2009)
Volume 135, Issue 1, Pages (July 2008)
Volume 64, Issue 6, Pages (June 2016)
Volume 138, Issue 5, Pages e2 (May 2010)
Short RNAs Repress Translation after Initiation in Mammalian Cells
Circadian Clock Control of Liver Metabolic Functions
Volume 127, Issue 1, Pages (July 2004)
Volume 127, Issue 6, Pages (December 2004)
Volume 137, Issue 1, Pages (July 2009)
A Role for REP Sequences in Regulating Translation
Volume 5, Issue 4, Pages (April 2000)
Volume 131, Issue 6, Pages (December 2006)
Volume 23, Issue 10, Pages (October 2015)
Volume 136, Issue 5, Pages e6 (May 2009)
Volume 18, Issue 2, Pages (April 2005)
Volume 129, Issue 5, Pages (November 2005)
Jun Zhan, Irudayam Maria Johnson, Matthew Wielgosz, Arthur W Nienhuis 
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
A Cell Cycle–Dependent Internal Ribosome Entry Site
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 15, Issue 5, Pages (May 2007)
Volume 142, Issue 4, Pages e4 (April 2012)
Volume 127, Issue 4, Pages (October 2004)
MicroRNA Destabilization Enables Dynamic Regulation of the miR-16 Family in Response to Cell-Cycle Changes  Olivia S. Rissland, Sue-Jean Hong, David P.
Ribosome Collision Is Critical for Quality Control during No-Go Decay
Volume 39, Issue 5, Pages (November 2003)
RNA Polymerase II Activity of Type 3 Pol III Promoters
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κB  Mitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi,
Volume 18, Issue 9, Pages (September 2010)
Transcriptional Regulation of AKT Activation by E2F
Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA Genome  Catherine L. Jopling, Sylvia Schütz,
Long-Term and Therapeutic-Level Hepatic Gene Expression of Human Factor IX after Naked Plasmid Transfer in Vivo  Carol H. Miao, Arthur R. Thompson, Keith.
Effects of silvestrol and BEZ235 on translation of MYC
Presentation transcript:

La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation  Masao Honda, Takeo Shimazaki, Shuichi Kaneko  Gastroenterology  Volume 128, Issue 2, Pages 449-462 (February 2005) DOI: 10.1053/j.gastro.2004.11.064 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Organization of the transcriptional unit of plasmid pRL-HL and pRL-(ΔIRES)-HL. (A) Plasmid pRL-HL22 contains a dicistronic CMV transcriptional cassette in which upstream Renilla and downstream firefly luciferase genes are separated by the complete 5′-NTR and 66-nt core sequence of HCV (nts 1–407; strain 1b) placed in the intercistronic space. (B) Plasmid pRL-(ΔIRES)-HL was the control plasmid of pRL-HL in which the functional HCV IRES element (nts 1–279) was deleted. CMV, cytomegalovirus promoter; T7, Bacteriophage T7 RNA polymerase promoter; BGH-pA, bovine growth hormone polyadenylation signal. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 HCV IRES-directed translation in confluent or serum-starved cells. (A) DNA content analysis of cell-cycle distribution in control, confluent, and serum-starved cells. (B) Changes in Renilla luciferase activities (cap-dependent translation) in confluent and serum-starved cells. (C) Changes in firefly luciferase activities (HCV IRES-directed translation) in confluent and serum-starved cells. (D) Changes in relative HCV IRES activities in confluent and serum-starved cells. (E) Ratios of firefly luciferase to Renilla luciferase mRNA determined by cDNA microarray. **P < .01. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Northern blotting of La protein, PTB, and albumin in RCF-26. Expression of La protein and PTB is repressed in confluent and serum-starved cells, whereas albumin expression is significantly up-regulated. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 HCV IRES activity and cell-cycle progression. (A) Changes in distribution with cell-cycle progression. Proportions of G1, S, and G2/M are individually shown. (B) Changes of Renilla luciferase activities (cap-dependent translation) with cell-cycle progression. (C) Changes in relative HCV IRES activities (firefly to Renilla luciferase activities; FL/RL) with cell-cycle progression. HCV IRES activity varied with cell cycle in RCF-26 cells but did not change in ΔRCF-9 cells. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 Gene-expression profiling in RCF-26 cells undergoing cell-cycle progression. RCF-26 cells were synchronized at the G1/S border with aphidicolin. After release from aphidicolin block, the cell cycle progressed to S phase at 3–6 hours and G2/M phase at 15–18 hours and returned to G1 phase at 24–30 hours. Cells were harvested at 3, 9, 15, 18, 24, 30, 36, and 42 hours and analyzed with cDNA microarray, and then an SOM was constructed by using Cluster (Stanford University). Gene clusters up-regulated in the S, G2/M, and G1 phases (red) were detected with cell-cycle progression. Canonical and noncanonical initiation factors and cell cycle-related genes are listed (right). Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 6 La protein expression in RCF-26 under cell-cycle progression determined by RTD-PCR. Normalized Cy5/Cy3 of mRNA expression of La protein and HCV IRES activities are shown in same dimension. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 7 Suppression of HCV IRES-related canonical and noncanonical initiation factors (La protein, PTB, eIF3 [p170], eIF2γ, RNPL, PABPC-1, PCBP-2, and ribosomal protein S9) by specific antisense phosphorothioate oligos and HCV IRES activity in RCF-26 and ΔRCF-9. (A) Changes in Renilla (cap-dependent translation) and firefly luciferase (HCV IRES-directed translation) activities caused by suppression of these factors by antisense phosphorothioate oligos. *P < .05. (B) Suppression of factors confirmed by RT-PCR. (C) Suppression of factors confirmed by Western blotting. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 8 (A) Overexpression of HCV IRES-related canonical and noncanonical initiation factors (La protein, PTB, eIF3 [p170], eIF2γ, RNPL, PCBP-1, PCBP-2, and ribosomal protein S9) in RCF-26 and HCV IRES activity. (B-D) Dose-dependent overexpression of La protein, PTB, and eIF3 p170 in RCF-26 and ΔRCF-9. *P < .05; **P < .01. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 9 Correlation of La protein (A), PTB (B), and eIF3 p170 (C) with the amount of HCV RNA in tissue lesions of chronic hepatitis C. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 10 La protein expression and HCV RNA in liver. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 11 Hepatitis and HCV life cycle. Gastroenterology 2005 128, 449-462DOI: (10.1053/j.gastro.2004.11.064) Copyright © 2005 American Gastroenterological Association Terms and Conditions